Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1980 Nov;133(5):383–391.

Drug Withdrawal Syndromes

A Literature Review

Glenn C Hodding 1,2, Michael Jann 1,2, Irving P Ackerman 1,2
PMCID: PMC1272349  PMID: 7008358

Abstract

Drug withdrawal syndromes reportedly have been caused by numerous pharmacological agents, but only a few drugs have been adequately studied in this regard. Criteria for evaluating drug withdrawal syndromes have been proposed. Sedative-hypnotic agents, opiates, corticosteroids, clonidine, tricyclic antidepressant medications and beta-adrenergic blocking agents meet the criteria for such syndromes. Gradual tapering of the dose of these drugs is recommended when therapy must be discontinued. Whether or not other drugs cause rebound reactions is questionable, but caution should be used when discontinuing drugs for which numerous reports of withdrawal syndromes exist.

Full text

PDF
383

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boudoulas H., Lewis R. P., Kates R. E., Dalamangas G. Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. Ann Intern Med. 1977 Oct;87(4):433–436. doi: 10.7326/0003-4819-87-4-433. [DOI] [PubMed] [Google Scholar]
  2. Brown G. M., Stancer H. C., Moldofsky H., Harman J., Murphy J. T., Gupta R. N. Withdrawal from long-term high-dose desipramine therapy. Clinical and biological changes. Arch Gen Psychiatry. 1978 Oct;35(10):1261–1264. doi: 10.1001/archpsyc.1978.01770340111012. [DOI] [PubMed] [Google Scholar]
  3. Byyny R. L. Withdrawal from glucocorticoid therapy. N Engl J Med. 1976 Jul 1;295(1):30–32. doi: 10.1056/NEJM197607012950107. [DOI] [PubMed] [Google Scholar]
  4. Côté P., Lamontagne R., Campeau L., Bourassa M. G. Risks of discontinuing anticoagulant therapy in a selected group of patients with atherosclerotic heart disease: a prospective study. Can Med Assoc J. 1977 Dec 3;117(11):1281–1284. [PMC free article] [PubMed] [Google Scholar]
  5. Dandavino R., Trunet P., Descamps B., Kreis H. Prolonged withdrawal of azathioprine in kidney transplantation. Transplant Proc. 1978 Sep;10(3):655–657. [PubMed] [Google Scholar]
  6. Demers-Desrosiers L. A., Nestoros J. N., Vaillancourt P. Acute psychosis precipitated by withdrawal of anticonvulsant medication. Am J Psychiatry. 1978 Aug;135(8):981–982. doi: 10.1176/ajp.135.8.981. [DOI] [PubMed] [Google Scholar]
  7. Dysken M. W., Chan C. H. Diazepam withdrawal psychosis: a case report. Am J Psychiatry. 1977 May;134(5):573–573. doi: 10.1176/ajp.134.5.573. [DOI] [PubMed] [Google Scholar]
  8. Frewin D. B., Penhall R. K. Rebound hypertension after sudden discontinuation of methyldopa therapy. Med J Aust. 1977 Apr 30;1(18):659–659. doi: 10.5694/j.1326-5377.1977.tb130994.x. [DOI] [PubMed] [Google Scholar]
  9. GRABER A. L., NEY R. L., NICHOLSON W. E., ISLAND D. P., LIDDLE G. W. NATURAL HISTORY OF PITUITARY-ADRENAL RECOVERY FOLLOWING LONG-TERM SUPPRESSION WITH CORTICOSTEROIDS. J Clin Endocrinol Metab. 1965 Jan;25:11–16. doi: 10.1210/jcem-25-1-11. [DOI] [PubMed] [Google Scholar]
  10. Gardos G., Cole J. O., Tarsy D. Withdrawal syndromes associated with antipsychotic drugs. Am J Psychiatry. 1978 Nov;135(11):1321–1324. doi: 10.1176/ajp.135.11.1321. [DOI] [PubMed] [Google Scholar]
  11. Gualtieri C. T., Staye J. Withdrawal symptoms after abrupt cessation of amitriptyline in an eight-year-old boy. Am J Psychiatry. 1979 Apr;136(4A):457–458. [PubMed] [Google Scholar]
  12. Gudeman J. E., Shader R. I., Hemenway T. S. Methadone withdrawal in the treatment of heroin addiction. Dis Nerv Syst. 1972 May;33(5):297–303. [PubMed] [Google Scholar]
  13. Harding T. Depression following fenfluramine withdrawal. Br J Psychiatry. 1972 Sep;121(562):338–339. doi: 10.1192/bjp.121.3.338-a. [DOI] [PubMed] [Google Scholar]
  14. Haselager E. M., Vreeken J. Rebound thrombocytosis after alcohol abuse: a possible factor in the pathogenesis of thromboembolic disease. Lancet. 1977 Apr 9;1(8015):774–775. doi: 10.1016/s0140-6736(77)92957-9. [DOI] [PubMed] [Google Scholar]
  15. Hershman J. M., Givens J. R., Cassidy C. E., Astwood E. B. Long-term outcome of hyperthyroidism treated with antithyroid drugs. J Clin Endocrinol Metab. 1966 Aug;26(8):803–807. doi: 10.1210/jcem-26-8-803. [DOI] [PubMed] [Google Scholar]
  16. Holowach J., Thurston D. L., O'Leary J. Prognosis in childhood epilepsy. Follow-up study of 148 cases in which therapy had been suspended after prolonged anticonvulsant control. N Engl J Med. 1972 Jan 27;286(4):169–174. doi: 10.1056/NEJM197201272860401. [DOI] [PubMed] [Google Scholar]
  17. Hoste P., Ingels J., Elewaut A., Barbier F. Duodenal perforation after cimetidine. Lancet. 1978 Mar 25;1(8065):666–666. doi: 10.1016/s0140-6736(78)91177-7. [DOI] [PubMed] [Google Scholar]
  18. Hughes R. C., Polgar J. G., Weightman D., Walton J. N. Levodopa in Parkinsonism: the effects of withdrawal of anticholinergic drugs. Br Med J. 1971 May 29;2(5760):487–491. doi: 10.1136/bmj.2.5760.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Husserl F. E., deCarvalho J. G., Batson H. M., Frohlich E. D. Hypertension after clonidine withdrawal. South Med J. 1978 May;71(5):496–497. doi: 10.1097/00007611-197805000-00006. [DOI] [PubMed] [Google Scholar]
  20. ISBELL H. Abuse of barbiturates. J Am Med Assoc. 1956 Oct 13;162(7):660–661. doi: 10.1001/jama.1956.02970240042012. [DOI] [PubMed] [Google Scholar]
  21. ISBELL H., WHITE W. M. Clinical characteristics of addictions. Am J Med. 1953 May;14(5):558–565. doi: 10.1016/0002-9343(53)90371-4. [DOI] [PubMed] [Google Scholar]
  22. Jackson A. H., Shader R. I. Guidelines for the withdrawal of narcotic and general depressant drugs. Dis Nerv Syst. 1973 Mar;34(3):162–166. [PubMed] [Google Scholar]
  23. KRAMER J. C., KLEIN D. F., FINK M. Withdrawal symptoms following dicontinuation of imipramine therapy. Am J Psychiatry. 1961 Dec;118:549–550. doi: 10.1176/ajp.118.6.549. [DOI] [PubMed] [Google Scholar]
  24. Kales A., Bixler E. O., Tan T. L., Scharf M. B., Kales J. D. Chronic hypnotic-drug use. Ineffectiveness, drug-withdrawal insomnia, and dependence. JAMA. 1974 Feb 4;227(5):513–517. [PubMed] [Google Scholar]
  25. Kamath V. R., Thorne M. G. Ischaemic heart-disease and withdrawal of anticoagulant therapy. Lancet. 1969 May 24;1(7604):1025–1027. doi: 10.1016/s0140-6736(69)91823-6. [DOI] [PubMed] [Google Scholar]
  26. Khantzian E. J., McKenna G. J. Acute toxic and withdrawal reactions associated with drug use and abuse. Ann Intern Med. 1979 Mar;90(3):361–372. doi: 10.7326/0003-4819-90-3-361. [DOI] [PubMed] [Google Scholar]
  27. Koch-Weser J., Sellers E. M., Kalant H. Alcohol intoxication and withdrawal. N Engl J Med. 1976 Apr 1;294(14):757–762. doi: 10.1056/NEJM197604012941405. [DOI] [PubMed] [Google Scholar]
  28. Kristensen B. O., Steiness E., Weeke J. Propranolol withdrawal and thyroid hormones in patients with essential hypertension. Clin Pharmacol Ther. 1978 Jun;23(6):624–629. doi: 10.1002/cpt1978236624. [DOI] [PubMed] [Google Scholar]
  29. Lacoursiere R. B., Spohn H. E., Thompson K. Medical effects of abrupt neuroleptic withdrawal. Compr Psychiatry. 1976 Mar-Apr;17(2):285–294. doi: 10.1016/0010-440x(76)90002-x. [DOI] [PubMed] [Google Scholar]
  30. Lees A. J., Clarke C. R., Harrison M. J. Hallucinations after withdrawal of baclofen. Lancet. 1977 Apr 16;1(8016):858–858. doi: 10.1016/s0140-6736(77)92809-4. [DOI] [PubMed] [Google Scholar]
  31. Lipkowitz M. H., Schwartz D. W., Lazarus R. J. Abrupt withdrawal of maintenance methadone. JAMA. 1971 Sep 27;217(13):1860–1861. [PubMed] [Google Scholar]
  32. Mascia A. V., Friedman E. A., Kornfield M. A. Clinical experience with long-term cromolyn sodium administration in 53 asthmatic children. Ann Allergy. 1976 Jul;37(1):1–7. [PubMed] [Google Scholar]
  33. Maxmen J. S., Silberfarb P. M., Plakun E. Pentazocine abuse and problems of withdrawal. Br J Psychiatry. 1975 Apr;126:370–371. doi: 10.1192/bjp.126.4.370. [DOI] [PubMed] [Google Scholar]
  34. Melby J. C. Drug spotlight program: systemic corticosteroid therapy: pharmacology and endocrinologic considerations. Ann Intern Med. 1974 Oct;81(4):505–512. doi: 10.7326/0003-4819-81-4-505. [DOI] [PubMed] [Google Scholar]
  35. Miller R. R., Olson H. G., Amsterdam E. A., Mason D. T. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975 Aug 28;293(9):416–418. doi: 10.1056/NEJM197508282930902. [DOI] [PubMed] [Google Scholar]
  36. Miller R. R. Propoxyphene: a review. Am J Hosp Pharm. 1977 Apr;34(4):413–423. [PubMed] [Google Scholar]
  37. Mizgala H. F., Counsell J. Acute coronary syndromes following abrupt cessation of oral propranolol therapy. Can Med Assoc J. 1976 Jun 19;114(12):1123–1126. [PMC free article] [PubMed] [Google Scholar]
  38. Moffatt T. L., Schwartz A. Rebound thrombocytosis after alcohol withdrawal. N Engl J Med. 1976 Dec 2;295(23):1322–1323. doi: 10.1056/nejm197612022952323. [DOI] [PubMed] [Google Scholar]
  39. Nattel S., Rangno R. E., Van Loon G. Mechanism of propranolol withdrawal phenomena. Circulation. 1979 Jun;59(6):1158–1164. doi: 10.1161/01.cir.59.6.1158. [DOI] [PubMed] [Google Scholar]
  40. Nibbelink D. W., Torner J. C., Henderson W. G. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage. Stroke. 1975 Nov-Dec;6(6):622–629. doi: 10.1161/01.str.6.6.622. [DOI] [PubMed] [Google Scholar]
  41. O'Donoghue D. P., Dawson A. M., Powell-Tuck J., Bown R. L., Lennard-Jones J. E. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet. 1978 Nov 4;2(8097):955–957. doi: 10.1016/s0140-6736(78)92524-2. [DOI] [PubMed] [Google Scholar]
  42. Pitt B. Letter: Withdrawal symptoms after stopping phenelzine? Br Med J. 1974 May 11;2(5914):332–333. doi: 10.1136/bmj.2.5914.332-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Pittman J. G., Maloof F. Hypothyroidism with unusual features following propylthiouracil therapy of Graves' disease. Am J Med Sci. 1972 Dec;264(6):499–505. doi: 10.1097/00000441-197212000-00010. [DOI] [PubMed] [Google Scholar]
  44. Preis O., Choi S. J., Rudolph N. Pentazocine withdrawal syndrome in the newborn infant. Am J Obstet Gynecol. 1977 Jan 15;127(2):205–206. doi: 10.1016/s0002-9378(16)33256-2. [DOI] [PubMed] [Google Scholar]
  45. Preskorn S. H., Denner L. J. Benzodiazepines and withdrawal psychosis. Report of three cases. JAMA. 1977 Jan 3;237(1):36–38. [PubMed] [Google Scholar]
  46. Rahbar F. Observations on methadone withdrawal in 16 neonates. Clin Pediatr (Phila) 1975 Apr;14(4):369–371. doi: 10.1177/000992287501400408. [DOI] [PubMed] [Google Scholar]
  47. Rosenblum J. A. Diphenylhydantoin sodium (Dilantin) withdrawal in non-epileptics. Curr Ther Res Clin Exp. 1971 Jun;13(6):369–373. [PubMed] [Google Scholar]
  48. Rothstein P., Gould J. B. Born with a habit. Infants of drug-addicted mothers. Pediatr Clin North Am. 1974 May;21(2):307–321. [PubMed] [Google Scholar]
  49. SALASSA R. M., BENNETT W. A., KEATING F. R., Jr, SPRAGUE R. G. Postoperative adrenal cortical insufficiency; occurrence in patients previously treated with cortisone. J Am Med Assoc. 1953 Aug 15;152(16):1509–1515. doi: 10.1001/jama.1953.03690160009004. [DOI] [PubMed] [Google Scholar]
  50. Sathananthan G. L., Gershon S. Imipramine withdrawal: an akathisia-like syndrome. Am J Psychiatry. 1973 Nov;130(11):1286–1287. doi: 10.1176/ajp.130.11.1286. [DOI] [PubMed] [Google Scholar]
  51. Scott J. N., McDevitt D. G. Letter: Rebound hypertension after acute methyldopa withdrawal. Br Med J. 1976 Aug 7;2(6031):367–367. doi: 10.1136/bmj.2.6031.367-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Shah P. K. Ventricular unloading in the management of heart disease: role of vasodilators. Part II. Am Heart J. 1977 Mar;93(3):403–406. doi: 10.1016/s0002-8703(77)80261-5. [DOI] [PubMed] [Google Scholar]
  53. Shaw M. D., Miller J. D. Letter: Epsilon-aminocaproic acid and subarachnoid haemorrhage.?211. Lancet. 1974 Oct 5;2(7884):847–848. doi: 10.1016/s0140-6736(74)91120-9. [DOI] [PubMed] [Google Scholar]
  54. Shenkman L., Podrid P., Lowenstein J. Hyperthyroidism after propranolol withdrawal. JAMA. 1977 Jul 18;238(3):237–239. [PubMed] [Google Scholar]
  55. Shiroff R. A., Mathis J., Zelis R., Schneck D. W., Babb J. D., Leaman D. M., Hayes A. H., Jr Propranolol rebound--a retrospective study. Am J Cardiol. 1978 Apr;41(4):778–780. doi: 10.1016/0002-9149(78)90831-7. [DOI] [PubMed] [Google Scholar]
  56. Slogoff S., Keats A. S., Ott E. Preoperative propranolol therapy and aortocoronary bypass operation. JAMA. 1978 Sep 29;240(14):1487–1490. [PubMed] [Google Scholar]
  57. Smith D. E., Wesson D. R. Phenobarbital technique for treatment of barbiturate dependence. Arch Gen Psychiatry. 1971 Jan;24(1):56–60. doi: 10.1001/archpsyc.1971.01750070058007. [DOI] [PubMed] [Google Scholar]
  58. Spiegel R. J., Vigersky R. A., Oliff A. I., Echelberger C. K., Bruton J., Poplack D. G. Adrenal suppression after short-term corticosteroid therapy. Lancet. 1979 Mar 24;1(8117):630–633. doi: 10.1016/s0140-6736(79)91077-8. [DOI] [PubMed] [Google Scholar]
  59. Swartzburg M., Lieb J., Schwartz A. H. Methaqualone withdrawal. Arch Gen Psychiatry. 1973 Jul;29(1):46–47. doi: 10.1001/archpsyc.1973.04200010027004. [DOI] [PubMed] [Google Scholar]
  60. Thompson W. L., Johnson A. D., Maddrey W. L. Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial. Ann Intern Med. 1975 Feb;82(2):175–180. doi: 10.7326/0003-4819-82-2-175. [DOI] [PubMed] [Google Scholar]
  61. Van Cleve R. The rebound phenomenon-fact or fancy? Experience with discontinuation of long-term anticoagulation therapy after myocardial infarction. Circulation. 1965 Dec;32(6):878–880. doi: 10.1161/01.cir.32.6.878. [DOI] [PubMed] [Google Scholar]
  62. Wallace E. R., Staton M. A. Acute hypertension after abrupt withdrawal of antipsychotic medication. South Med J. 1977 Apr;70(4):395–395. [PubMed] [Google Scholar]
  63. Wallace W. A., Orr C. M., Bearn A. R. Perforation of chronic peptic ulcers after cimetidine. Br Med J. 1977 Oct 1;2(6091):865–866. doi: 10.1136/bmj.2.6091.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Webster P. A. Withdrawal symptoms in neonates associated with maternal antidepressant therapy. Lancet. 1973 Aug 11;2(7824):318–319. doi: 10.1016/s0140-6736(73)90815-5. [DOI] [PubMed] [Google Scholar]
  65. Whitlock F. A., Evans L. E. Drugs and depression. Drugs. 1978 Jan;15(1):53–71. doi: 10.2165/00003495-197815010-00004. [DOI] [PubMed] [Google Scholar]
  66. Whitsett T. L., Chrysant S. G., Dillard B. L., Anton A. H. Abrupt cessation of clonidine administration: a prospective study. Am J Cardiol. 1978 Jun;41(7):1285–1290. doi: 10.1016/0002-9149(78)90887-1. [DOI] [PubMed] [Google Scholar]
  67. Wilkinson D. G. Difficulty in stopping lithium prophylaxis? Br Med J. 1979 Jan 27;1(6158):235–236. doi: 10.1136/bmj.1.6158.235-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Zelson C. Infant of the addicted mother. N Engl J Med. 1973 Jun 28;288(26):1393–1395. doi: 10.1056/NEJM197306282882607. [DOI] [PubMed] [Google Scholar]
  69. de Bard M. L. Diazepam withdrawal syndrome: a case with psychosis, seizure, and coma. Am J Psychiatry. 1979 Jan;136(1):104–105. doi: 10.1176/ajp.136.1.104. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES